Ketamine-assisted Psychotherapy / AIMS vs. DEA – Part 1

This course page focuses on ketamine-assisted psychotherapy (KAP), including how ketamine is used off-label in clinical settings for PTSD, depression, anxiety, obsessive-compulsive disorder, eating disorders, addictions, and severe pain. It places KAP within the wider “psychedelic renaissance” and explains why ketamine is discussed separately from other hallucinogens because it can be legally prescribed off-label. The content includes an interview with Dr. Sunil Aggarwal of AIMS Institute in Seattle about clinical experience, patient screening, and the role of psychotherapy alongside ketamine treatment. It also touches on KAP for patients with cancer and other serious chronic illnesses, and describes the clinic’s whole-person approach. This page is relevant to clinicians, therapists, and others interested in psychedelic-assisted therapy, ketamine treatment, and the current evidence and regulatory landscape. The excerpt does not provide a formal course structure, assessment, certificate, or continuing education information.